The aspect of Pfizer's coronavirus vaccine that really stunned the company's scientists was the fact that vaccinated participants in the Phase 3 efficacy trial had protections against the pathogen by day 12, a time at which there was barely any antibody response, Stat News reports. "That was the biggest surprise," said Vidia Roopchand, Pfizer's principal scientist for viral vaccines.
Roopchand is still trying to figure exactly why that is — not that it's a bad thing — by poring over the data. One possibility is that other aspects of the immune system such as T-cells that Roopchand says have largely been neglected in immunology research may have played a significant role. It's possible, he suggested, that's more important to measure cellular immunity than look for a robust antibody response. "The 12-day protection data is telling us there's more to it," Roopchand told Stat. "This is a great time to learn."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
US foodies brace for tariff warUnder The Radar Shoppers stocking up on imported olive oil, maple syrup and European wine as price hikes loom
-
How Canadian tariffs could impact tourism to the USIn the Spotlight Canadians represent the largest group of foreign visitors to the United States. But they may soon stop visiting.
-
Entitlements: DOGE goes after Social SecurityFeature Elon Musk is pushing false claims about Social Security fraud
-
Texas outbreak brings 1st US measles death since 2015Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
-
Mystery illness spreading in Congo rapidly kills dozensSpeed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
-
Ozempic can curb alcohol cravings, study findsSpeed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
-
New form of H5N1 bird flu found in US dairy cowsSpeed Read This new form of bird flu is different from the version that spread through herds in the last year
-
Microplastics accumulating in human brains, study findsSpeed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
-
FDA approves painkiller said to thwart addictionSpeed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
-
Study finds possible alternative abortion pillSpeed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
-
How close are we to a norovirus vaccine?Today's Big Question A new Moderna trial raises hopes of vanquishing a stomach bug that sickens millions a year
